Record Revenue Growth
NEXGEL achieved record revenue growth, with a 181% increase in Q4 2024 revenue to $3.04 million compared to $1.08 million in Q4 2023, and a 112% increase in full-year 2024 revenue totaling $8.69 million compared to $4.09 million in 2023.
Successful Contract Manufacturing
Contract manufacturing significantly contributed to growth, driven by increased demand from existing customers and onboarding new global corporations such as Cintas and Owens & Minor.
Expansion of Consumer Products
The consumer products portfolio, including brands like Medagel, Kenkoderm, and Silly George, saw strong growth, with Silly George's revenue growing from $2 million to over $5 million.
Positive Partnership Developments
NEXGEL's partnership with STADA is progressing well, with product Histasolv exceeding projections and a contract amendment signed to expand the relationship.
Innovation and New Product Launches
NEXGEL launched a study on hydrogel efficacy for laser hair removal, with potential regulatory compliance and safety benefits. New product launches are planned for 2025, including expanded lines for Medagel and Kenkoderm.